Global IVD Quality Control Sector Poised for $2.28 Billion Valuation by 2031
Meticulous Research®—a
leading market research company, published a research report titled, ‘IVD Quality Control
Market Size, Share, Forecast & Trends
Analysis by Offering (Product [Serum, Blood], Data Management, Service)
Technology (Biochemistry, Molecular, Immunoassay) Application (cardiology,
Oncology) End User – Global Forecast to 2031’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=3447?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=20-11-2024
According
to this latest publication from Meticulous Research®, the IVD
quality control market is projected to reach $2.28 billion by 2031, at a
CAGR of 4.3% from 2024 to 2031. The growth of the IVD quality control
market is driven by the rising prevalence of chronic diseases, coupled with the
increasing geriatric population, growing demand for third-party quality
controls, need for internal and external quality assessment reports, increasing
number of clinical laboratories, growing demand for Point-of-Care (POC) and
rapid diagnostics. However, stringent technical requirements and regulatory
processes for quality controls restrain this market's growth.
Growing
demand for multi-analyte and multi-instrument controls offers opportunities for
market growth. However, evolving regulatory landscape and lack of access to
quality control/quality assurance materials are the major challenges to market
growth.
Key
Players
Key
companies operating in the IVD quality control market are Seimens Healthineers
AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.),
LGC Group (U.K.), Thermo Fisher Scientific Inc. (U.S.), SERO AS (Norway),
Randox Laboratories Ltd. (U.K.), QuidelOrtho Corporation (U.S.), Streck LLC
(U.S.), and Microbiologics, Inc. (U.S.), and Bio-Techne Corporation (U.S.)
The
IVD quality control market is segmented by Offering (Quality Control Products
{Quality Control Products, by Type [Serum/Plasma-based Controls, Whole
Blood-based Controls, Urine-based Controls, Other Controls], Quality Control
Products, by Function [Independent Controls, Instrument-specific Controls]},
Quality Assessment Services, Data Management Solutions); Technology
(Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular
Diagnostics, Hematology, Coagulation/Hemostasis, Microbiology, Other
Technologies); Application (Infectious Diseases, Oncology, Cardiology,
Autoimmune Disorders, Neurology, Other Applications); End User (Hospitals &
Clinics, Diagnostic Laboratories, Academic Institutes & Research
Laboratories, Other End Users), and Geography. The study also evaluates
industry competitors and analyzes the regional and country-level markets.
Among
the technology, in 2024, the
immunoassay/immunochemistry segment is expected to account for the largest
share of the IVD quality control market. Immunoassay/immunochemistry
advantages, such as inherent specificity, high-throughput, high sensitivity,
and low cost, are driving the growth of this technology segment. Further, the
increasing use of immunoassays in POC & infectious disease testing,
development of novel tests, increasing usage of miniaturized devices, and
rising demand for immunoassay-based tests support the increased demand for IVD
quality controls for immunoassays.
Among
the applications, in 2024, the
infectious diseases segment is expected to account for the largest share of the
IVD quality control market. The high prevalence of infectious diseases such as
HIV, dengue, influenza, and pneumonia, the emergence of pandemics such as COVID-19,
and supportive initiatives by public organizations to increase diagnostic
testing are the factors supporting the large market share of this segment. For
instance, According to UNAIDS estimates, in 2021, 38.4 million people were living
with HIV globally (36.7 million adults and 1.7 million children aged 0–14
years). Additionally, in 2021, 1.5 million new cases of HIV were reported
globally. This increased the usage of quality controls for infectious diseases.
Based
on end user, in 2024, the hospitals
& clinics segment is expected to account for the largest share of the IVD
quality control market. The large market segment share is majorly attributed to
the increasing prevalence of healthcare-associated infections (HAIs), the high
volume of diagnostic tests conducted in hospitals, the growth in healthcare
expenditure, and the expansion of hospitals and clinics in emerging markets.
Additionally, during the COVID-19 pandemic, hospital admissions increased with
the number of hospitals, leading to the high adoption of COVID-19 test quality
controls in hospitals & clinics.
Based
on geography, Asia-Pacific is
expected to register the highest growth rate over the forecast period. The
significantly growing IVD industry in the region with rising demand for early
diagnosis from the large patient population in Asia, rising number of accredited
laboratories, increasing number of hospitals and clinical pathologies,
increasing healthcare spending, and improving healthcare infrastructure in the
region are some of the major drivers for the growth of the Asia-Pacific market.
About Meticulous
Research®:
We are a
trusted research partner for leading businesses worldwide, empowering Fortune
500 organizations and emerging enterprises with actionable market intelligence
tailored to drive revenue transformation and strategic growth. Our insights
reveal forward-looking revenue opportunities, providing our clients with a
competitive edge through a diverse suite of research solutions—syndicated
reports, custom research, and direct analyst engagement.
Each year,
we conduct over 300 syndicated studies and manage 60+ consulting engagements
across eight key industry sectors and 20+ geographic markets. With a focus on
solving the complex challenges facing global business leaders, our research
enables informed decision-making that propels sustainable growth and
operational excellence. We are dedicated to delivering high-impact solutions
that transform business performance and fuel innovation in the competitive
global marketplace.
Contact
Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research
Meticulous Blog | Top Market Research Reports Blog - https://meticulousblog.org/
Comments
Post a Comment